ENCOD
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
October 11, 2007  |  By ENCOD In 2007

PROPOSAL FOR DIALOGUE ON DRUG POLICY

arton409

The European Commission is planning to start up a dialogue
process with civil society on drug policy this year. In the month of
september 2007, a budget of approx. 1 million EURO per year should
become available for citizens’ associations to take part in a dialogue
structure.

ENCOD believes it is important that all civil society associations
involved in this process, whatever their ideological background is,
are invited to this dialogue. We present the following proposal to the concrete form this dialogue should take.

For more information, read the Green Pepper.


PROPOSAL FOR A DIALOGUE ON DRUG POLICY IN THE EU

We would like to make the following proposal for the future dialogue
process between the European Commission and civil society on drug policy
in the European Union. This proposal is based on several years of
experience with dialogue processes concerning the multifaceted drugs phenomenon at a
European, national and local level, and on an analysis of dialogue
structures on other issues in the European Union.

This proposal contains suggestions for the objectives, methodology,
structure, framework, content, outcomes and practical organisation of the
dialogue.

Objectives

The objectives of the dialogue should be to engage all participants; and
enhance their understanding of the drug phenomenon. It is important to ensure
that a consensus amongst civil society organisations behind certain
recommendations that they may wish to make to policy-makers is the widest
possible, so that such recommendations can become clear signals to the institutions of the European Union.

Methodology

The methodology should be designed to create an environment where all participants can
feel confident. Civil society has long been ignored in the
drug policy-making process, so the first expectation is to be allowed
to speak and be listened to. On the other hand, it is important to avoid
the dialogue becoming a discussion where participants seek to impose their views rather than listening and understanding the views of others.

Structure

The detailed structure of the dialogue should be agreed upon by both
representatives of EU institutions and of civil society together. It should
respect the diversity of all existing networks and organisations.
Transparency and accessibility should be safeguarded during the entire
process.

A possible structure could consist of two instruments:

1. Independent body

An independent body can be created, with equal representation of
European networks of civil society organisations on one side and
European Union authorities on the other. The body (of max. 25 people) is
moderated by a Member of the European Parliament. This body meets twice
a year, in order to supervise the process that will take place in the
civil society forum (plenary session and working groups). Thus, it can
ensure that all decisions around the forum are taken in a transparent
way. This body discusses proposals to feed the dialogue process and the
follow up that may be given to the recommendations that arise from it.

Meetings of this body could coincide with the annual meetings of the
Horizontal Drugs Group where the EU Action Plan is evaluated, with the
aim of including the input from civil society in this evaluation process.

The European civil society representatives who would participate in this
independent body should be chosen by the civil society forum (see 2.).,
taking account of mechanisms to safeguard the geographic, organisational
and sectorial representativity. Ideally, they should cover the largest
possible number of affected and concerned citizens: consumers,
relatives, health workers, experts and involved citizens.

2. The civil society forum

A civil society forum on drug policy can be created, that is open and accessible
to all European civil society organisations working in the drugs field
which fulfil certain agreed criteria regarding transparency and representation.

The forum consists of one plenary session each year (to which all
participating organisations can be invited) and various specialist/sectoral sessions with a
number of smaller working group, that would deal with specific themes.
To these sessions representatives of the European Commission, Member
State Governments, the EMCDDA, EUROPOL and the European Parliament could
be invited as observers.

An Internet forum could be established to prepare these meetings and
follow up on them.

The aim of the civil society forum is to produce recommendations of both
the majority and minority of civil society representatives present, in
order to be included in the revision of the current EU Action Plan and
the design of forthcoming Action Plans.

Admission of participants

In order to identify the organisations that are invited to become a
member of the civil society forum, a survey can be elaborated.

All organisations who participated in the preparation phase of the
dialogue process as it has been carried out so far (Conference in
January 2006 and Responses on Green Paper of September 2006) will
receive such a survey, and will be asked to nominate other candidate
organisations who would receive a survey as well. On the basis of the
results of this survey a first selection can be made of organisations to
participate in the first civil society forum. Membership can be
rotating, so a large as possible number of organisations can participate
in this forum.

When selecting the composition of the forum, attention should be given
to the following criteria:

Priority should be given to representatives of European and national
networks, but if some weakness was identified during the preparatory
process concerning the coverage of some areas, the possibility for other
organisations that do not belong to any network and have expertise in
any concrete issue should be opened.

European networks should have member organisations in a significant
number of EU Member States.

Organisations should be able to prove that they have transparent rules
on membership and decision-making structures. In principle, membership
should be accessible to any citizen.

The admission of participants to the working groups could be established
according to various criteria, depending on the division of the working
groups.

These criteria can be based on the different sectors covered by drug
policies. They can also focus on specific issues that are cross-sectorial.

Working groups will produce recommendations in their specific area of
competence. These groups could be invited to produce annual reports, a
summary of which could be published as an annex to the annual report of the EMCDDA.

Content

The content of the dialogue could consist of the political agenda, based
on the evaluation and preparation of current and new European Union
Action Plans and Strategies on Drugs, as well as on issues that become
relevant during the course of the dialogue. In order to promote
authentic discussion in stead of strategic debates, it is also important
to include the possibility of discussing open questions such as:

How to design models for drug policy that effectively reduces the
accessibility of drugs to minors?

How to design models for drug policy that effectively improve people’s
lives?

How to improve coordination between initiatives of citizens and
authorities around drugs in Europe?

How to improve and share knowledge about long term efficacy of measures
and programmes aimed at reducing or avoiding drug related problems?

Result

The dialogue should aim to be an enrichening experience for all
participants. Thus it will automatically have a positive impact on the
process concerning drug policy in Europe. The concrete result could be
formulated within regular recommendations towards European Institutions
with regards to the current implementation of drug policies. Ideally,
these recommendations would be shared by the largest possible number of
civil society organisations.

On behalf of ENCOD,

Christine Kluge, Germany

 Marina Impallomeni, Italy

 Virginia Montañes, Spain

 Farid Ghehioueche, France

 Jan van der Tas, Netherlands

 Joep Oomen, Belgium

(Steering Committee)

EUROPEAN COALITION FOR JUST AND EFFECTIVE DRUG POLICIES

Lange Lozanastraat 14 – 2018 Antwerpen – Belgium

Tel. + 32 (0)3 293 0886 – Mob. + 32 (0)495 122644

E-mail: info@encod.org / encod.org

Previous StoryEL GOBIERNO NACIONAL DE COLOMBIA… MIENTE
Next StoryLA NEWSLETTER DI FUORILUOGO.IT

Related Articles

  • arton968
    REPORT ON FIRST CIVIL SOCIETY FORUM
  • arton963
    FOR A PROFESSIONNALLY ORGANISED DIALOGUE

Categories

Archives

  • About us
  • Downloads
  • Contact
  • Privacy Policy
  • Legal Notice & Terms of Use
  • Imprint

Copyright ©2018 ThemeFuse. All Rights Reserved

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT

REPUBLISHING TERMS

You may republish this article online or in print under our Creative Commons license. You may not edit or shorten the text, you must attribute the article to ENCOD and you must include the author’s name in your republication.

If you have any questions, please email thujer@gmail.com

License

Creative Commons License AttributionCreative Commons Attribution
PROPOSAL FOR DIALOGUE ON DRUG POLICY